Functional subtypes in patients with CIPN are not related to chemotherapy dose

Researchers have identified hidden subgroups within cancer survivors displaying distinct profiles of chemotherapy-induced peripheral neuropathy (CIPN). But despite assumptions within the field, no dose-response relationship was found.